In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata

被引：25
|
作者：
Oliveira, ER
Fothergill, AW
Kirkpatrick, WR
Coco, BJ
Patterson, TF
Redding, SW
机构：
[1] Univ Texas, Hlth Sci Ctr, Dept Gen Dent, San Antonio, TX 78229 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78229 USA
[3] Univ Texas, Hlth Sci Ctr, Dept Med, Div Infect Dis, San Antonio, TX 78229 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 08期
关键词：
D O I：
10.1128/AAC.49.8.3544-3545.2005
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Combinations of caspofungin and posaconazole were evaluated by fractional inhibitory concentration index against 119 Candida glabrata isolates. Synergy was seen in 18% of all isolates and in 4% of fluconazole-resistant isolates at 48 h without evidence of antagonism. This antifungal combination may have utility against this organism.
引用
收藏
页码：3544 / 3545
页数：2
相关论文
共 50 条
  • [41] Changes in susceptibility to posaconazole in clinical isolates of Candida albicans
    Li, X
    Brown, N
    Chau, AS
    López-Ribot, JL
    Ruesga, MT
    Quindos, G
    Mendrick, CA
    Hare, RS
    Loebenberg, D
    DiDomenico, B
    McNicholas, PM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (01) : 74 - 80
  • [42] Encephalartos villosus Lem. Displays a Strong In Vivo and In Vitro Antifungal Potential against Candida glabrata Clinical Isolates
    Alqahtani, Moneerah J.
    Elekhnawy, Engy
    Negm, Walaa A.
    Mahgoub, Sebaey
    Hussein, Ismail A.
    JOURNAL OF FUNGI, 2022, 8 (05)
  • [43] Comparative In Vitro Susceptibility of Clinical Isolates of Candida parapsilosis Complex and Other Candida Species to Caspofungin and Anidulafungin by Etest
    Khan, Z.
    Ahmad, S.
    Joseph, L.
    Chandy, R.
    Theyyathel, A.
    JOURNAL OF CHEMOTHERAPY, 2011, 23 (02) : 97 - 101
  • [44] Development of echinocandin resistance after in vitro micafungin exposure in clinical isolates of Candida glabrata
    Rivero-Menendez, O.
    Navarro-Rodriguez, P.
    Alastruey-Izquierdo, A.
    MEDICAL MYCOLOGY, 2018, 56 : S53 - S53
  • [45] Caspofungin as treatment for Candida glabrata hip infection
    Lejko-Zupanc, T
    Mozina, E
    Vrevc, F
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 25 (03) : 273 - 274
  • [46] In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms
    Nagy, Fruzsina
    Toth, Zoltan
    Nyikos, Fanni
    Forgacs, Lajos
    Jakab, Agnes
    Borman, Andrew M.
    Majoros, Laszlo
    Kovacs, Renato
    MEDICAL MYCOLOGY, 2021, 59 (10) : 1015 - 1023
  • [47] In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance
    Bachmann, SP
    Patterson, TF
    López-Ribot, JL
    JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) : 2228 - 2230
  • [48] Candida glabrata endophthalmitis treated successfully with caspofungin
    Sarria, JC
    Bradley, JC
    Habash, R
    Mitchell, KT
    Kimbrough, RC
    Vidal, AM
    CLINICAL INFECTIOUS DISEASES, 2005, 40 (05) : E46 - E48
  • [49] In vitro activity of caspofungin against Candida albicans biofilms
    Bachmann, SP
    VandeWalle, K
    Ramage, G
    Patterson, TF
    Wickes, BL
    Graybill, JR
    López-Ribot, JL
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) : 3591 - 3596
  • [50] In vitro interaction of voriconazole with imipenem/cilastatin and piperacillin/tazobactam against clinical Candida albicans isolates
    Ozcan, S. E. M. A. Keceli
    Mutlu, B.
    MYCOSES, 2009, 52 : 111 - 111
12345